As of 2024-12-14, the Fair Value of Antibe Therapeutics Inc (ATE.TO) is -1.77 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.30 CAD, the upside of Antibe Therapeutics Inc is -701.01%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 5Y Avg | |
| Net income | -12.82 | -19.34 | -26.30 | -25.06 | -19.48 | -20.60 |
| YoY growth | -72.54% | -50.86% | -35.99% | 4.71% | 22.27% | -26.48% |
| Market Cap (mil) | 15.53 |
| P/E | |
| Forward P/E |
| EPS | -0.35 |
| Avg earnings growth rate | -26.48% |
| TTM earnings | -18.67 |